HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is an urgent as well as huge medical challenge, which is associated with poor prognosis and responsiveness to chemotherapies. Since epigenetic changes are highly implicated in TNBC tumorigenesis and development, inhibitors of histone deacetylases (HDACIs) could r...

Descripción completa

Detalles Bibliográficos
Autores principales: Maccallini, Cristina, Ammazzalorso, Alessandra, De Filippis, Barbara, Fantacuzzi, Marialuigia, Giampietro, Letizia, Amoroso, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230362/
https://www.ncbi.nlm.nih.gov/pubmed/35745586
http://dx.doi.org/10.3390/ph15060667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230362/
https://www.ncbi.nlm.nih.gov/pubmed/35745586
http://dx.doi.org/10.3390/ph15060667

Ejemplares similares